73 articles in this topic
University of Zurich researchers tested psilocybin against placebo in 37 alcohol-dependent patients using rigorous double-blind methodology.
60-person study tested psilocybin alone and with CBT for major depression, measuring brain activity and inflammatory markers.
University researchers used psychedelic therapy and brain imaging to tackle cocaine addiction, revealing new neural pathways for recovery.
Large 6-year study tested dietary interventions including caloric restriction and omega-3s in 330 people with mild cognitive impairment.
Small pilot study tests multicomponent behavioral program to reduce cognitive decline risk in underserved rural populations.
18-month trial tested omega-3 supplementation in 774 older adults with low DHA/EPA levels and memory concerns to prevent cognitive decline.
French researchers followed 1,028 people with mild cognitive complaints to understand how dementia develops over time.
Nine-year study investigated whether solanezumab could slow memory decline in older adults with brain amyloid plaques.
Italian researchers investigated whether intensive exercise could slow Parkinson's progression by reducing inflammation and boosting protective factors.
Completed study of 102 older adults tested whether combined interventions can preserve brain volume and improve mobility through muscle-brain axis.
Age-tailored cognitive behavioral intervention tested in 20 older women with binge eating disorder in pilot study.
Pilot study tests psilocybin-assisted psychotherapy to help hospice patients overcome demoralization and existential suffering.
